Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
about
Biocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and EndolysinsAntimicrobial bacteriophage-derived proteins and therapeutic applicationsCrystal structure of the antimicrobial peptidase lysostaphin fromStaphylococcus simulansEngineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogensBiochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.Bacteriophages and Their Immunological Applications against Infectious Threats.'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium.Bacteriophage endolysins as novel antimicrobials.Engineered bacteriophage lysins as novel anti-infectivesEfficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection.Fine-tuned characterization of Staphylococcus aureus Newbould 305, a strain associated with mild and chronic mastitis in bovines.Mitrecin A, an endolysin-like bacteriolytic enzyme from a newly isolated soil streptomycete.Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation.Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococciBacteriophage PBC1 and its endolysin as an antimicrobial agent against Bacillus cereus.Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis.RETRACTED: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.Selection of single-chain variable fragments specific for Mycobacterium tuberculosis ESAT-6 antigen using ribosome displayBacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations.Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureusEffects of Chinese Propolis in Protecting Bovine Mammary Epithelial Cells against Mastitis Pathogens-Induced Cell Damage.Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivoPhage lytic proteins: biotechnological applications beyond clinical antimicrobials.Phage lytic enzymes: a history.Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Genetically modified bacteriophages in applied microbiology.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.Immobilized phage proteins for specific detection of staphylococci.The tape measure protein of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 has an active muramidase domain.Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.Corrected and Republished from: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.Effective Antimicrobial Activity of Plectasin-Derived Antimicrobial Peptides against Staphylococcus aureus Infection in Mammary Glands.Bacteriophage ΦSA012 Has a Broad Host Range against Staphylococcus aureus and Effective Lytic Capacity in a Mouse Mastitis Model.
P2860
Q26752523-93F9EB40-0237-4B30-B7CF-47CD42C607D8Q26781115-3B9706C8-4937-45D6-A94A-6643F9DD6B3DQ27684730-ECC799B3-BDDA-44E5-A5F4-0E32D3486E67Q28243174-3E4D9ABC-4D03-4124-86B0-9CDDBCB99D73Q30009348-B4195809-0881-434F-9FF7-C1B70D981B7AQ30234522-28C83BE1-E149-4296-8F58-4530E3A51F6CQ30825736-480AC323-F3F5-4545-ABB2-0AE6D3BBDE44Q33870844-53997B2D-2990-443D-A729-70F83CB53601Q34303439-38B267C6-A308-462E-93A2-D2542D550A4EQ34349552-DFF6993E-E334-4BEB-8114-D9A4765F812CQ34394175-BB8001B8-EB0A-40AB-9EDA-C2627CA700ABQ34503012-795616DB-EE57-4B46-87D9-16376000121BQ34548813-B1F6D6BA-A243-489A-BBB4-E13643986C11Q34566563-5A2CF2A5-26C5-4520-8621-1D1A586D3DF9Q35158325-0673BE97-0393-48B7-B375-2A4521428F9FQ35172146-1A795A60-1C94-4ABC-A248-7936D65EB599Q35653429-B1596DCA-B7D8-40C7-A8FE-D2E6A95C3B48Q35808669-E667373D-2C3D-4AB5-9917-286AAEC4545EQ35842148-87D5FFDF-825C-4A09-A190-0987D60D00A3Q36070204-CBBC9510-7035-49C4-8BC6-3FF481C7AC88Q36270490-7F5EC157-06FD-48BE-9908-945E89497856Q36341519-A66830FF-44E5-4B29-9175-F3C6A2428A17Q36823396-9DD40F35-3CD5-49AB-A47C-47D60EDDF601Q36845812-ADD5706E-2037-442A-8A97-573240E7C469Q37084371-8E8B248D-EC0B-40CC-A9CA-8EA6ACA83759Q37544464-93E46FE3-0357-4162-BB7B-526521F36256Q38325227-0E07E9F7-C526-49E5-B68C-12DB27921A3EQ38348307-1F2AB6AC-23B6-4D4C-81D7-1D238AE65A5CQ38392069-0519E51E-D2BE-42BD-AAD8-869A6DA904D0Q38810296-4062E4C1-9599-4F50-A0E2-D29E75C9AD2BQ38870317-70FEF186-1DB9-4827-8EE6-CC7A5CA50DA4Q39029801-B31004C4-FB98-4CCA-A7FB-3900AF1BD38EQ41457130-8DC90284-949F-403B-9F14-75A89EC9940BQ42239980-9B444FB0-625C-4C60-B349-EF3BC3685092Q42271272-8C5AE2B7-6840-4BA8-BD91-7B10A5ED6C58Q43245858-93D51A3B-4302-45E7-A3EE-E1357C3B9C51Q46251747-D0AD65D5-0A71-4B32-ADB5-91EC9942B14DQ47112473-F81D5635-C52B-4884-8A1A-B6BB5F17FC0DQ47129788-1E3E6323-AB7F-4B7E-A67B-20E25E40419AQ47556647-064445CC-CC9A-498C-84C2-E0FCD766B6F3
P2860
Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@ast
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@en
type
label
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@ast
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@en
prefLabel
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@ast
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@en
P2093
P2860
P356
P1476
Chimeric phage lysins act syne ...... reus in murine mammary glands.
@en
P2093
Anne M Powell
David M Donovan
Mary J Camp
Mathias Schmelcher
Stephen C Becker
P2860
P304
P356
10.1128/AEM.07050-11
P407
P577
2012-01-27T00:00:00Z